2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Esophageal Neoplasms
7
Malnutrition
5
Pancreatic Neoplasms
3
Stomach Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Cachexia
2
Weight Loss
1
Postoperative Complications
1
Pancreatitis, Chronic
1
Nutritional Support
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Carcinoma
1
Muscular Atrophy
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Infections
1
Hyperphagia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Deglutition Disorders
1
Critical Illness
1
Cholangiocarcinoma
1
Child Nutrition Disorders
1
Interventions
ostarine
3
rimabotulinumtoxinB
1
Standard of Care
1
Olanzapine
1
Exercise
1
Enteral Nutrition
1
Electric Stimulation
1
Eicosapentaenoic Acid
1
Diet Therapy
1
Cyproheptadine
1
Creatine
1
Carnitine
1
Botulinum Toxins, Type A
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Muscular Atrophy
×
Enteral Nutrition
×
Clear all
NCT06175273
2025-09-18
POINT
University of Kentucky
Phase 2/3
Completed
19 enrolled